Advertisement

Update 1988 pp 528-534 | Cite as

Clinical Use of Benzodiazepine Antagonists

  • P. Lheureux
  • R. Askenasi
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 5)

Abstract

The benzodiazepins were introducted in the early sixties. Their various pharmacological properties and their high toxic/therapeutic ratio explain the wide development of their clinical use (and abuse?). Their mechanism of action on the central nervous system (CNS) was only elucidated in 1977 when high affinity binding sites, closely related to GABA-ergic synapses, were discovered in the mammalian cerebral cortex and related to the pharmacologic action of benzodiazepines [1, 2]. A specific antagonist of benzodiazepine-receptors (Ro 15-1788 — flumazenil), able to inhibit all the effects of classical benzodiazepines without inducing any own action, was discovered by Hunkeleer et al. in 1981 [3].

Keywords

Hepatic Encephalopathy Inverse Agonist Central Receptor Partial Inverse Agonist Mammalian Cerebral Cortex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Squires RF, Braestrup C (1977) Benzodiazepine receptors in rat brain. Nature 266:732–734.PubMedCrossRefGoogle Scholar
  2. 2.
    Molher H, Okada T (1977) Benzodiazepine receptor: demonstration in the central nervous system. Science 198:849–851.CrossRefGoogle Scholar
  3. 3.
    Hunkeleer W, Mohler H, Pieri L, et al (1981) Selective antagonists of benzodiazepines. Nature 290:514–516.CrossRefGoogle Scholar
  4. 4.
    Mohler H, Richards JG, Wu JY (1981) Autoradiographic localisation of benzodiazepine receptors in immunocytochemically identified GABA ergic synapses. Proc Natl Acad Sci 78:1935–1938.PubMedCrossRefGoogle Scholar
  5. 5.
    Polc P, Bonetti EP, Schaffner R, Haefely W (1982) A three-state model of the benzodiazepine receptor explains the interaction between the benzodiazepine antagonist Ro 15-1788, BZD tranquilizers, B-carbolines, and phenobarbitone. Naunyn-Schmiedelberg’s Arch Pharmacol 321:260–264.CrossRefGoogle Scholar
  6. 6.
    Richards JG, Mohler H, Haefely W (1982) Benzodiazepine binding sites: receptors or acceptors? TIPS 3:233–235.Google Scholar
  7. 7.
    Mestre M, Carriot T, Belin C, et al (1984) Electrophysiological and pharmacological characterization of peripheral benzodiazepine receptors in guinea pig heart preparation. Life Sci 35:953–962.PubMedCrossRefGoogle Scholar
  8. 8.
    Mestre M, Carriot T, Belin C, et al (1985) Electrophysiological and pharmacological evidence that peripheral-type benzodiazepine receptors are coupled to calcium channels in the heart. Life Sci 36:391–400.PubMedCrossRefGoogle Scholar
  9. 9.
    Le Fur G, Vaucher N, Perrier ML, et al (1983) Differentiation between two ligands for peripheral benzodiazepine binding sites, (3H) Ro 5-4864 and (3H) PK 11195 by thermodynamic studies. Life Sci 33:449–457.PubMedCrossRefGoogle Scholar
  10. 10.
    Hofer P, Scollo Lavizzari G (1985) Benzodiazepine antagonist RO 15-1788 in self-poisoning: diagnostic and therapeutic use. Arch Intern Med 145:663–664.PubMedCrossRefGoogle Scholar
  11. 11.
    Lheureux P, Askenasi R (1987) Specific treatment of benzodiazepine overdose. Human Toxicology (in press).Google Scholar
  12. 12.
    O’Sullivan GF, Wade DN (1987) Flumazenil in the management of acute drug overdosage with benzodiazepines and other agents. Clin Pharmacol Ther 42:254–259.PubMedCrossRefGoogle Scholar
  13. 13.
    Klotz U, Ziegler G, Reimann IW (1984) Pharmacokinetics of the selective benzodiazepine antagonist RO-15-1788 in man. Eur Clin Pharmacol 27:115–117.Google Scholar
  14. 14.
    Klotz U, Ziegler G, Ludwig L, Reimann IW (1985) Pharmacodynamic interaction between midazolam an a specific benzodiazepine antagonist in humans. J Clin Pharmacol 25:400–406.PubMedGoogle Scholar
  15. 15.
    Lheureux P, Askenasi R (1986) Benzodiazepine antagonist RO 15-1788 in acute alcohol intoxication. Toxicology Letters 31(s): 155 (abstract).Google Scholar
  16. 16.
    Louis M, Forster A, Suter PM, Gemperle M (1984) Clinical and hemodynamic effects of a specific benzodiazepine antagonist (Ro 15-1788) after open heart surgery. Anaesthesiology 61:A61.CrossRefGoogle Scholar
  17. 17.
    Lheureux P, Askenasi R (1986) Treatment of benzodiazepine overdose with RO 15-1788. Arch Intern Med 146:1241 (letter).PubMedCrossRefGoogle Scholar
  18. 18.
    Havoudjian H, Reed GF, Paul SM, Skolnick P (1987) Protection against the lethal effects of pentobarbital in mice by a benzodiazepine inverse agonist, 6,7-dimethoxy-4-ethyl-3-carbomethoxy-B-carboline. J Clin Invest 79:473–477.CrossRefGoogle Scholar
  19. 19.
    Sage JD, Close A, Boas RA (1987) Reversal of midazolam sedation with anexate. Br J Anaesth 59:459–464.PubMedCrossRefGoogle Scholar
  20. 20.
    Ricou B, Forster A, Bruckner A, Chastonay P, Gemperle M (1986) Clinical evaluation of a specific benzodiazepine antagonist (Ro 15-1788). Studies in elderly patients after regional anaesthesia under benzodiazepine sedation. Br J Anaesth 58:1005–1011.PubMedCrossRefGoogle Scholar
  21. 21.
    Wolff J, Carl P, Clausen TG, Mikkelsen BO (1986) Ro 15-1788 for post operative recovery. A randomized clinical trial in patients undergoing minor surgical procedures under midazolam anesthesia. Anaesthesia 41:1001–1006.PubMedCrossRefGoogle Scholar
  22. 22.
    Samson Y, Bernuau J, Pappata S, Chavoix C, Baron JC, Maziere MA (1987) Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy. N Engl J Med 316:414–415.PubMedCrossRefGoogle Scholar
  23. 23.
    Baraldi M, Zeneroli ML, Ventura E, et al (1984) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin Sci 67:167–175.PubMedGoogle Scholar
  24. 24.
    Scollo-Lavizzari G, Steinmann E (1985) Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788) (letter). Lancet 1:1324.CrossRefGoogle Scholar
  25. 25.
    Bansky G, Meier PJ, Ziegler WH, Walser H, Schmid M, Huber M (1985) Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788). Lancet 1:1324–1325 (letter).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • P. Lheureux
  • R. Askenasi

There are no affiliations available

Personalised recommendations